FEB 08, 2017 12:25 PM PST

Two B Cells Types, Two Completely Different Life Roles

WRITTEN BY: Kara Marker

A specialized form of immune B cells exist in the human spleen to protect the body from specific types of bacteria. But there is a unique molecular process that needs to happen in order for immature B cells to become these specialized cells over other types of cells.

From The Flanders Institute for Biotechnology (VIB), researchers investigated the pathways behind the differentiation of specialized B cells called MZB cells, named for the marginal zone in the spleen where they congregate. The spleen plays the important role of filtering the blood for bacteria and other foreign particles. 

A  section taken from a spleen reveals splenic tissue with sheets of immune cells. Source: Cytopath Veterinary Pathology Laboratory

MZB cells are involved in antibody “training” to prepare them for the fight against infectious disease, mainly producing antibodies that target encapsulated bacterial like pneumococcus. However, MZB cells are not the only immune cells doing work in the spleen. They share some space with another B cell subtype called follicular B cells, so what makes precursor cells “decide” to become MZB cells versus follicular B cells?

"We had a 'eureka!' moment after discovering that a little-known protein, Taok3, brings a certain proteinase, ADAM10, to the surface of the immature B cell that triggers its development into an MZB cell,” explained VIB’s Hamida Hammad. “Without that special event, immature B cells can only develop into follicular B cells." Hammad and the team from VIB started their study with the knowledge that Taok3 protein triggers, somehow, the development of MZB cells.

Identifying the role of Taok3 protein in the development of MZB cells provides new possibilities for treatments of genetic conditions, asthma, and diabetes, which might rely on the immune response which includes MZB cells.

VIB researchers confirmed the role of Taok3 in mice studies by removing the Taok3 gene. Without it, the mice would make almost any B cell type except MZB cells. They were also especially susceptible to respiratory infection from pneumococcus bacteria.

"With an abundance of only follicular B cells, Taok3-free mice are less capable of fighting these types of bacteria effectively,” Hammad said.

“This research has generated insights that are very relevant to new therapies to a range of important diseases,” said VIB’s Bart Lambrecht. “It goes to show that basic science sometimes leads to unexpected - and important - applications."

The VIB’s new study was published in the journal Nature Immunology.

Source: The Flanders Institute for Biotechnology (VIB)

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 07, 2020
Microbiology
Second COVID-19 Vaccine Enters Human Trials
APR 07, 2020
Second COVID-19 Vaccine Enters Human Trials
Yesterday, Inovio Pharmaceuticals, Inc. announced that it will begin human trials on a potential vaccine for COVID-19.
APR 14, 2020
Immunology
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 21, 2020
Immunology
A Nasal Vaccine Against Tau Tangles
APR 21, 2020
A Nasal Vaccine Against Tau Tangles
  One of the hallmarks of Alzheimer’s disease (AD) is the accumulation of “tau tangles”. Tau is a ...
MAY 15, 2020
Immunology
Support the Microbiome So the Immune System Can Do Its Job
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
MAY 19, 2020
Drug Discovery & Development
COVID-19 Vaccine On Track for Late 2020
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
MAY 26, 2020
Immunology
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
MAY 26, 2020
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
The immune landscape is staggeringly complex, with a myriad of genetically and functionally distinct immune cell subpopu ...
Loading Comments...